Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
71.50
-2.23 (-3.02%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $233.73 million as of June 3, 2026. Its market cap has increased by 987.13% in one year.
Market Cap
233.73M
Enterprise Value
181.77M
1-Year Change
987.13%
Ranking
Category
Stock Price
$71.50
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $233.73M, an increase of 2.38%. That is a compound annual growth rate of 0.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 233.70M | 99.06% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 252.26M |
| Cellectis | 249.39M |
| SAB Biotherapeutics | 244.56M |
| Codexis | 244.51M |
| Protara Therapeutics | 243.93M |
| Indaptus Therapeutics | 243.47M |
| AC Immune | 240.07M |
| ALX Oncology Holdings | 239.52M |